Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.45 - $0.86 $39 - $74
87 Added 1.71%
5,168 $2,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.63 $13 - $18
-30 Reduced 0.59%
5,081 $3,000
Q2 2022

Aug 12, 2022

SELL
$0.47 - $0.87 $46 - $85
-98 Reduced 1.88%
5,111 $2,000
Q1 2022

May 16, 2022

SELL
$0.75 - $1.77 $6,182 - $14,590
-8,243 Reduced 61.28%
5,209 $4,000
Q4 2021

Feb 08, 2022

BUY
$1.56 - $2.93 $1,410 - $2,648
904 Added 7.2%
13,452 $21,000
Q3 2021

Nov 15, 2021

SELL
$2.91 - $4.83 $54,053 - $89,717
-18,575 Reduced 59.68%
12,548 $38,000
Q2 2021

Sep 13, 2021

BUY
$4.17 - $5.74 $129,782 - $178,646
31,123 New
31,123 $145,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.